A behind-the-scenes look at DIAGNODE-3: Phase 3 clinical trials of Diamyd® for T1D
DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.
Breakthrough T1D Mourns Tragic, Sudden Loss of Five Ride Champions
The leadership, staff, and volunteers of Breakthrough T1D mourn the recent loss of five T1D Champions.
The Kelley Family: Enduring to Cure T1D
The Kelley family is involved with our organization in every way possible. But for Margaret Kelley, our endurance event is…
The Merwin Family: Aiming for the Ultimate Finish Line
The Merwin Family found their purpose with our organization after their child was diagnosed with T1D.
Meet Our New International Board of Directors Vice Chair, Matt Varey
Matt Varey, the newly elected Vice Chair of the Breakthrough T1D International Board of Directors (IBOD), brings a truly global…
Meet Our New International Board of Directors Chair, Lisa F. Wallack
Lisa F. Wallack, newly elected Chair of the Breakthrough T1D International Board of Directors, is carrying on her family's legacy…
Looking for type 1 diabetes support? Breakthrough T1D is here for you!
Living with type 1 diabetes can be overwhelming at times, but you’re never alone. Breakthrough T1D is here to provide…
Breakthrough T1D Advocates, A Voice for the T1D Community
Breakthrough T1D Advocates use the most powerful tools they have—their own personal stories—to raise awareness and power progress for the…
Breakthrough T1D Honors Dedicated Volunteers and Supporters
The Breakthrough T1D 2022 Volunteer Award recipients have shown innovation, dedication, and lifted up those around them.
